z-logo
open-access-imgOpen Access
The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial
Author(s) -
Yuliya Knyahnytska,
Reza Zomorrodi,
Tyler S. Kaster,
Daphne Voineskos,
Alisson Paulino Trevizol,
Daniel M. Blumberger
Publication year - 2021
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/30163
Subject(s) - electroconvulsive therapy , ketamine , treatment resistant depression , medicine , major depressive disorder , clinical trial , depression (economics) , pharmacotherapy , transcranial magnetic stimulation , antidepressant , anesthesia , psychiatry , stimulation , mood , hippocampus , economics , macroeconomics , electroconvulsive shock

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom